Andy Kuo

Dr Andy Kuo is a Senior Research Fellow and Assistant Director at the Centre for Integrated Preclinical Drug Development (CIPDD), a Tier 2 Infrastructure Centre located in the School of Biomedical Sciences at UQ. With expertise in preclinical translational research, in the last ten years Dr Kuo in the role of Study Director, has managed the conduct of numerous R&D contract-funded and collaborative research grant-funded studies that are/have been undertaken in accordance with the requirements of CIPDD’s electronic Quality Management System (eQMS), which is rare in Australia.

To date he has successfully conducted/managed over 60 research projects, conducted in accordance with the requirements of CIPDD’s eQMS framework. His extensive experience encompasses experimental procedures and the management of preclinical studies, particularly in the areas of animal model development/validation, pharmacodynamic readouts, pharmacokinetics, and toxicology.

Despite the demands of working in an NCRIS (National Collaborative Research Infrastructure Strategy)-funded National Centre that is a key partner in Therapeutic Innovation Australia’s (TIA) Small Molecule Therapeutics Capability focused on IP-sensitive research, he has sustained a robust publication record, with 32 publications and 2 book chapters. Additionally, he has submitted 46 commercial-in-confidence study reports to industry and academic collaborators contributing significantly to the field of novel therapeutics innovation.